PDS Biotechnology Corp Operating Expenses
PDS Biotechnology Corp (PDSB) reported Operating Expenses of $6.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- PDS Biotechnology Corp operating expenses for the quarter ending 2026-06-30 was $6.50M, a 14.78% decline year-over-year.
- PDS Biotechnology Corp operating expenses for the quarter ending 2026-03-31 was $6.52M, a 28.39% decline year-over-year.
- PDS Biotechnology Corp operating expenses for the quarter ending 2025-12-31 was $6.67M, a 9.32% decline year-over-year.
- PDS Biotechnology Corp operating expenses for the quarter ending 2025-09-30 was $8.14M, a 20.03% decline year-over-year.
- PDS Biotechnology Corp operating expenses for fiscal 2025 was $31.54M, a 13.15% decline from fiscal 2024.
- PDS Biotechnology Corp operating expenses for fiscal 2024 was $36.32M, a 15.62% decline from fiscal 2023.
- PDS Biotechnology Corp operating expenses for fiscal 2023 was $43.05M, a 3.29% increase from fiscal 2022.
- PDS Biotechnology Corp operating expenses for fiscal 2022 was $41.67M, a 94.37% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.50M 10-Q · filed 2026-08-13 | $13.02M 10-Q · filed 2026-08-13 | $19.69M derived: sum of 3 quarters · filed 2026-08-13 | $27.83M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $6.52M 10-Q · filed 2026-05-14 | $13.20M derived: sum of 2 quarters · filed 2026-05-14 | $21.34M derived: sum of 3 quarters · filed 2026-05-14 | $28.96M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $14.81M derived: sum of 2 quarters · filed 2026-03-30 | $22.44M derived: sum of 3 quarters · filed 2026-08-13 | $31.54M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $8.14M 10-Q · filed 2025-11-13 | $15.76M derived: sum of 2 quarters · filed 2026-08-13 | $24.87M 10-Q · filed 2025-11-13 | $32.23M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $7.62M 10-Q · filed 2026-08-13 | $16.73M 10-Q · filed 2026-08-13 | $24.09M derived: sum of 3 quarters · filed 2026-08-13 | $34.27M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $9.11M 10-Q · filed 2026-05-14 | $16.47M derived: sum of 2 quarters · filed 2026-05-14 | $26.65M derived: sum of 3 quarters · filed 2026-05-14 | $35.33M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $7.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $17.54M derived: sum of 2 quarters · filed 2026-03-30 | $26.22M derived: sum of 3 quarters · filed 2026-03-30 | $36.32M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $10.18M 10-Q · filed 2025-11-13 | $18.86M derived: sum of 2 quarters · filed 2025-11-13 | $28.96M 10-Q · filed 2025-11-13 | $39.37M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $8.68M 10-Q · filed 2025-08-13 | $18.78M 10-Q · filed 2025-08-13 | $29.19M derived: sum of 3 quarters · filed 2025-08-13 | $39.71M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $10.10M 10-Q · filed 2025-05-14 | $20.50M derived: sum of 2 quarters · filed 2025-05-14 | $31.02M derived: sum of 3 quarters · filed 2025-05-14 | $43.72M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $10.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $20.93M derived: sum of 2 quarters · filed 2025-03-27 | $33.62M derived: sum of 3 quarters · filed 2025-03-27 | $43.05M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $10.52M 10-Q · filed 2024-11-14 | $23.22M derived: sum of 2 quarters · filed 2024-11-14 | $32.64M 10-Q · filed 2024-11-14 | $51.46M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $12.70M 10-Q · filed 2024-08-13 | $22.12M 10-Q · filed 2024-08-13 | $40.94M derived: sum of 3 quarters · filed 2024-08-13 | $48.22M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $9.42M 10-Q · filed 2024-05-15 | $28.24M derived: sum of 2 quarters · filed 2024-05-15 | $35.52M derived: sum of 3 quarters · filed 2024-05-15 | $42.62M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $18.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $26.10M derived: sum of 2 quarters · filed 2024-03-28 | $33.19M derived: sum of 3 quarters · filed 2024-03-28 | $41.67M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $7.28M 10-Q · filed 2023-11-14 | $14.37M derived: sum of 2 quarters · filed 2023-11-14 | $22.85M 10-Q · filed 2023-11-14 | $29.17M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $7.09M 10-Q · filed 2023-08-14 | $15.57M 10-Q · filed 2023-08-14 | $21.89M derived: sum of 3 quarters · filed 2023-08-14 | $28.86M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $8.48M 10-Q · filed 2023-05-15 | $14.80M derived: sum of 2 quarters · filed 2023-05-15 | $21.76M derived: sum of 3 quarters · filed 2023-05-15 | $26.87M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $13.28M derived: sum of 2 quarters · filed 2023-03-28 | $18.39M derived: sum of 3 quarters · filed 2023-03-28 | $21.44M 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | $6.96M 10-Q · filed 2022-11-14 | $12.07M derived: sum of 2 quarters · filed 2022-11-14 | $15.12M 10-Q · filed 2022-11-14 | $19.15M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $5.11M 10-Q · filed 2022-08-08 | $8.16M 10-Q · filed 2022-08-08 | $12.18M derived: sum of 3 quarters · filed 2022-08-08 | $16.09M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $3.05M 10-Q · filed 2022-05-11 | $7.08M derived: sum of 2 quarters · filed 2022-05-11 | $10.98M derived: sum of 3 quarters · filed 2022-05-11 | $13.92M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $7.93M derived: sum of 2 quarters · filed 2022-03-31 | $10.87M derived: sum of 3 quarters · filed 2022-03-31 | $14.90M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $3.91M 10-Q · filed 2021-11-10 | $6.84M derived: sum of 2 quarters · filed 2021-11-10 | $10.87M 10-Q · filed 2021-11-10 | $16.86M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $2.94M 10-Q · filed 2021-08-12 | $6.97M 10-Q · filed 2021-08-12 | $12.95M derived: sum of 3 quarters · filed 2021-08-12 | $18.80M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $4.03M 10-Q · filed 2021-05-13 | $10.01M derived: sum of 2 quarters · filed 2021-05-13 | $15.86M derived: sum of 3 quarters · filed 2021-05-13 | $20.13M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $5.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $11.83M derived: sum of 2 quarters · filed 2021-03-18 | $16.10M derived: sum of 3 quarters · filed 2021-03-18 | $21.03M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $5.85M 10-Q · filed 2020-11-13 | $10.12M derived: sum of 2 quarters · filed 2020-11-13 | $15.05M 10-Q · filed 2020-11-13 | $16.69M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $4.27M 10-Q · filed 2020-08-13 | $9.21M 10-Q · filed 2020-08-13 | $10.84M derived: sum of 3 quarters · filed 2020-08-13 | $11.55M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $4.94M 10-Q · filed 2020-05-13 | $6.57M derived: sum of 2 quarters · filed 2020-05-13 | $7.28M derived: sum of 3 quarters · filed 2020-05-13 | $7.85M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $2.34M derived: sum of 2 quarters · filed 2020-03-27 | $2.91M derived: sum of 3 quarters · filed 2020-03-27 | $3.65M 10-K · filed 2020-03-27 | $43.10M 10-K · filed 2019-02-21 | |||
| 2018-09-30 | $710.27K 10-Q · filed 2019-11-07 | $4.45M 10-Q · filed 2018-11-01 | $1.28M derived: sum of 2 quarters · filed 2019-11-07 | $2.01M 10-Q · filed 2019-11-07 | $37.05M 10-Q · filed 2018-11-01 | $18.14M derived: sum of 4 quarters · filed 2019-11-07 | ||
| 2018-06-30 | $567.03K 10-Q · filed 2019-08-01 | $12.51M 10-Q · filed 2018-08-01 | $1.30M 10-Q · filed 2019-08-01 | $32.60M 10-Q · filed 2018-08-01 | $17.43M derived: sum of 3 quarters · filed 2019-08-01 | $28.33M derived: sum of 4 quarters · filed 2019-08-01 | ||
| 2018-03-31 | $736.94K 10-Q · filed 2019-05-14 | $20.10M 10-Q · filed 2018-05-01 | $16.86M derived: sum of 2 quarters · filed 2019-05-14 | $27.76M derived: sum of 3 quarters · filed 2019-05-14 | $40.91M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | $16.12M 10-K · filed 2018-03-01 | $27.03M derived: sum of 2 quarters · filed 2018-11-01 | $40.18M derived: sum of 3 quarters · filed 2018-11-01 | $51.97M 10-K · filed 2019-02-21 | ||||
| 2017-09-30 | $10.90M 10-Q · filed 2018-11-01 | $24.05M derived: sum of 2 quarters · filed 2018-11-01 | $35.84M 10-Q · filed 2018-11-01 | $46.78M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | $13.15M 10-Q · filed 2018-08-01 | $24.94M 10-Q · filed 2018-08-01 | $35.88M derived: sum of 3 quarters · filed 2018-08-01 | $46.16M derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2017-03-31 | $11.79M 10-Q · filed 2018-05-01 | $22.73M derived: sum of 2 quarters · filed 2018-05-01 | $33.01M derived: sum of 3 quarters · filed 2018-05-01 | $42.27M derived: sum of 4 quarters · filed 2018-05-01 | ||||
| 2016-12-31 | $10.94M 10-K · filed 2018-03-01 | $21.22M derived: sum of 2 quarters · filed 2018-03-01 | $30.48M derived: sum of 3 quarters · filed 2018-03-01 | $39.51M 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | $10.28M 10-K · filed 2018-03-01 | $10.28M 10-Q · filed 2016-11-01 | $19.54M derived: sum of 2 quarters · filed 2018-03-01 | $28.57M 10-Q · filed 2017-11-01 | $37.44M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $9.26M 10-K · filed 2018-03-01 | $9.26M 10-Q · filed 2016-08-03 | $18.30M 10-Q · filed 2017-08-01 | $27.17M derived: sum of 3 quarters · filed 2018-03-01 | $35.65M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $9.03M 10-K · filed 2018-03-01 | $9.03M 10-Q · filed 2016-05-03 | $17.90M derived: sum of 2 quarters · filed 2018-03-01 | $26.39M derived: sum of 3 quarters · filed 2018-03-01 | $31.35M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $8.87M 10-K · filed 2017-03-02 | $17.36M derived: sum of 2 quarters · filed 2017-03-02 | $22.32M derived: sum of 3 quarters · filed 2017-03-02 | $26.50M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $8.48M 10-K · filed 2017-03-02 | $8.48M 10-Q · filed 2015-11-06 | $13.45M derived: sum of 2 quarters · filed 2017-03-02 | $17.63M 10-Q · filed 2016-11-01 | $21.64M derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-06-30 | $4.96M 10-K · filed 2017-03-02 | $9.14M 10-Q · filed 2016-08-03 | $13.16M derived: sum of 3 quarters · filed 2017-03-02 | $16.72M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-03-31 | $4.18M 10-K · filed 2017-03-02 | $8.20M derived: sum of 2 quarters · filed 2017-03-02 | $11.76M derived: sum of 3 quarters · filed 2017-03-02 | $14.91M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2014-12-31 | $4.02M 10-K · filed 2016-03-08 | $7.58M derived: sum of 2 quarters · filed 2016-03-08 | $10.73M derived: sum of 3 quarters · filed 2016-03-08 | $13.19M 10-K · filed 2017-03-02 | ||||
| 2014-09-30 | $3.56M 10-K · filed 2016-03-08 | $3.56M 10-Q · filed 2015-11-06 | $6.71M derived: sum of 2 quarters · filed 2016-03-08 | $9.18M 10-Q · filed 2015-11-06 | ||||
| 2014-06-30 | $3.15M 10-K · filed 2016-03-08 | $5.62M derived: sum of 2 quarters · filed 2016-03-08 | ||||||
| 2014-03-31 | $2.46M 10-K · filed 2016-03-08 | |||||||
| 2013-12-31 | $6.49M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |